Literature DB >> 16305988

Nucleolar adaptation in human cancer.

Leonard B Maggi1, Jason D Weber.   

Abstract

While the nucleolus was first observed over two hundred years ago, its role in human cancers is only now being appreciated. Long thought to be a static, ribosome-producing, subnuclear organelle, recent investigations have shown a more dynamic and adaptable side of the nucleolus. Containing not only proteins for the production of ribosomes but also newfound nucleolar oncogenes and tumor suppressors, mechanistic links between the nucleolus and cancer are now more evident. In this regard, much of the work from the past decade has focused on the ability of these proteins to promote and suppress tumorigenesis from the nucleolus. In this review, we will discuss how historical measurements of the nucleolus are being translated into contemporary studies of nucleolar dysfunction in human cancer.

Entities:  

Mesh:

Year:  2005        PMID: 16305988      PMCID: PMC1403297          DOI: 10.1080/07357900500283085

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  132 in total

Review 1.  The multiple roles of PTEN in tumor suppression.

Authors:  A Di Cristofano; P P Pandolfi
Journal:  Cell       Date:  2000-02-18       Impact factor: 41.582

2.  Identification of a cryptic nucleolar-localization signal in MDM2.

Authors:  M A Lohrum; M Ashcroft; M H Kubbutat; K H Vousden
Journal:  Nat Cell Biol       Date:  2000-03       Impact factor: 28.824

3.  In situ hybridization at the electron microscope level: an improved method for precise localization of ribosomal DNA and RNA.

Authors:  M Thiry; L Thiry-Blaise
Journal:  Eur J Cell Biol       Date:  1989-10       Impact factor: 4.492

Review 4.  eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation.

Authors:  A C Gingras; B Raught; N Sonenberg
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

5.  Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization.

Authors:  M A Lohrum; M Ashcroft; M H Kubbutat; K H Vousden
Journal:  Curr Biol       Date:  2000-05-04       Impact factor: 10.834

6.  Inhibition of v-Abl transformation by p53 and p19ARF.

Authors:  F Cong; X Zou; K Hinrichs; K Calame; S P Goff
Journal:  Oncogene       Date:  1999-12-16       Impact factor: 9.867

Review 7.  Prognostic relevance of AgNORs in tumor pathology.

Authors:  A Pich; L Chiusa; E Margaria
Journal:  Micron       Date:  2000-04       Impact factor: 2.251

8.  Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.

Authors:  J D Weber; M L Kuo; B Bothner; E L DiGiammarino; R W Kriwacki; M F Roussel; C J Sherr
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

9.  Potent inhibitors of cyclin-dependent kinase 2 induce nuclear accumulation of wild-type p53 and nucleolar fragmentation in human untransformed and tumor-derived cells.

Authors:  T David-Pfeuty
Journal:  Oncogene       Date:  1999-12-09       Impact factor: 9.867

10.  Nucleolar organizer regions in meningioma.

Authors:  T Orita; K Kajiwara; T Nishizaki; N Ikeda; T Kamiryo; H Aoki
Journal:  Neurosurgery       Date:  1990-01       Impact factor: 4.654

View more
  37 in total

Review 1.  Recent progress in histochemistry and cell biology.

Authors:  Stefan Hübner; Athina Efthymiadis
Journal:  Histochem Cell Biol       Date:  2012-02-25       Impact factor: 4.304

2.  Nucleolar dominance and maternal control of 45S rDNA expression.

Authors:  Katarzyna Michalak; Sebastian Maciak; Young Bun Kim; Graciela Santopietro; Jung Hun Oh; Lin Kang; Harold R Garner; Pawel Michalak
Journal:  Proc Biol Sci       Date:  2015-12-07       Impact factor: 5.349

Review 3.  When ribosomes go bad: diseases of ribosome biogenesis.

Authors:  Emily F Freed; Franziska Bleichert; Laura M Dutca; Susan J Baserga
Journal:  Mol Biosyst       Date:  2010-01-11

4.  Differential expression of ribosomal proteins in a human metastasis model identified by coupling 2-D liquid chromatography and mass spectrometry.

Authors:  Paweena Kreunin; Chul Yoo; Virginia Urquidi; David M Lubman; Steve Goodison
Journal:  Cancer Genomics Proteomics       Date:  2007 Sep-Oct       Impact factor: 4.069

5.  Regulation of E2F1-induced apoptosis by the nucleolar protein RRP1B.

Authors:  Jason C Paik; Bing Wang; Kang Liu; Jerry K Lue; Weei-Chin Lin
Journal:  J Biol Chem       Date:  2009-12-29       Impact factor: 5.157

6.  Nucleophosmin serves as a rate-limiting nuclear export chaperone for the Mammalian ribosome.

Authors:  Leonard B Maggi; Michael Kuchenruether; David Y A Dadey; Rachel M Schwope; Silvia Grisendi; R Reid Townsend; Pier Paolo Pandolfi; Jason D Weber
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

7.  Nucleolar localization and identification of nuclear/nucleolar localization signals of the calmodulin-binding protein nucleomorphin during growth and mitosis in Dictyostelium.

Authors:  Andrew Catalano; Danton H O'Day
Journal:  Histochem Cell Biol       Date:  2011-02-17       Impact factor: 4.304

8.  Identification of DHX33 as a mediator of rRNA synthesis and cell growth.

Authors:  Yandong Zhang; Jason T Forys; Alexander P Miceli; Abigail S Gwinn; Jason D Weber
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

Review 9.  Structure and epigenetics of nucleoli in comparison with non-nucleolar compartments.

Authors:  Eva Bártová; Andrea Harnicarová Horáková; Radka Uhlírová; Ivan Raska; Gabriela Galiová; Darya Orlova; Stanislav Kozubek
Journal:  J Histochem Cytochem       Date:  2009-12-21       Impact factor: 2.479

10.  A novel gene, ANKRD28 on 3p25, is fused with NUP98 on 11p15 in a cryptic 3-way translocation of t(3;5;11)(p25;q35;p15) in an adult patient with myelodysplastic syndrome/acute myelogenous leukemia.

Authors:  Maho Ishikawa; Fumiharu Yagasaki; Daisuke Okamura; Tomoya Maeda; Yuichi Sugahara; Itsuro Jinnai; Masami Bessho
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.